Targeting Autophagy for Acetaminophen-Induced Liver Injury: An Update.

Area of Science:

• Hepatology
• Cellular Biology
• Toxicology

Background:

• Acetaminophen (APAP) overdose is a leading cause of acute liver failure.
• APAP metabolism generates a reactive metabolite, NAPQI, leading to protein adducts and mitochondrial damage.
• Autophagy plays a role in clearing cellular damage.

Purpose of the Study:

• To review the role of autophagy in acetaminophen-induced liver injury (AILI).
• To discuss the potential of targeting autophagy pathways for AILI treatment.

Main Methods:

• Literature review of studies on autophagy and AILI.
• Focus on the roles of SQSTM1/p62 and TFEB in AILI.

Main Results:

• Autophagy activation is increasingly recognized as a protective mechanism in AILI.
• SQSTM1/p62 and TFEB are key regulators of autophagy that can be pharmacologically targeted.
• Targeting these pathways shows promise for mitigating liver damage.

Conclusions:

• Autophagy activation is a promising therapeutic strategy for AILI.
• Pharmacological targeting of SQSTM1/p62 and TFEB warrants further investigation for AILI treatment.
• Understanding autophagy modulation is crucial for managing APAP overdose.